Medpace Holdings, Inc. (MEDP)

USD 305.11

(0.95%)

Revenue Summary of Medpace Holdings, Inc.

  • Medpace Holdings, Inc.'s latest annual revenue in 2023 was 1.88 Billion USD , up 29.17% from previous year.
  • Medpace Holdings, Inc.'s latest quarterly revenue in 2024 Q3 was 533.31 Million USD , up 0.99% from previous quarter.
  • Medpace Holdings, Inc. reported a annual revenue of 1.45 Billion USD in annual revenue 2022, up 27.8% from previous year.
  • Medpace Holdings, Inc. reported a annual revenue of 1.14 Billion USD in annual revenue 2021, up 23.38% from previous year.
  • Medpace Holdings, Inc. reported a quarterly revenue of 528.1 Million USD for 2024 Q2, up 3.34% from previous quarter.
  • Medpace Holdings, Inc. reported a quarterly revenue of 511.04 Million USD for 2024 Q1, up 2.54% from previous quarter.

Annual Revenue Chart of Medpace Holdings, Inc. (2023 - 2013)

Historical Annual Revenue of Medpace Holdings, Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 1.88 Billion USD 29.17%
2022 1.45 Billion USD 27.8%
2021 1.14 Billion USD 23.38%
2020 925.92 Million USD 7.54%
2019 860.96 Million USD 22.19%
2018 704.58 Million USD 61.55%
2017 436.15 Million USD 3.46%
2016 421.58 Million USD 17.41%
2015 359.05 Million USD 23.8%
2014 290.04 Million USD 6.28%
2013 272.89 Million USD 0.0%

Peer Revenue Comparison of Medpace Holdings, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -5934.888%
Applied DNA Sciences, Inc. 13.36 Million USD -14007.724%
Aspira Women's Health Inc. 9.15 Million USD -20501.289%
Biodesix, Inc. 49.08 Million USD -3741.836%
BioNexus Gene Lab Corp. 9.77 Million USD -19200.782%
bioAffinity Technologies, Inc. 2.53 Million USD -74365.656%
bioAffinity Technologies, Inc. 2.53 Million USD -74365.656%
Bionano Genomics, Inc. 36.11 Million USD -5121.625%
CareDx, Inc 280.32 Million USD -572.737%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD -758.028%
DarioHealth Corp. 20.35 Million USD -9166.126%
Exact Sciences Corporation 2.49 Billion USD 24.559%
Fulgent Genetics, Inc. 289.21 Million USD -552.06%
Guardant Health, Inc. 563.94 Million USD -234.4%
ICON Public Limited Company 8.12 Billion USD 76.776%
IDEXX Laboratories, Inc. 3.66 Billion USD 48.488%
Illumina, Inc. 4.5 Billion USD 58.13%
Intelligent Bio Solutions Inc. 3.11 Million USD -60503.301%
iSpecimen Inc. 9.92 Million USD -18894.833%
Standard BioTools Inc. 106.34 Million USD -1673.408%
MDxHealth SA 70.19 Million USD -2586.653%
23andMe Holding Co. 219.63 Million USD -758.614%
Myriad Genetics, Inc. 678.4 Million USD -177.984%
Mainz Biomed B.V. 895.47 Thousand USD -210495.893%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD -218.747%
Neogen Corporation 924.22 Million USD -104.046%
Inotiv, Inc. 572.42 Million USD -229.448%
Natera, Inc. 1.08 Billion USD -74.2%
OPKO Health, Inc. 863.49 Million USD -118.396%
Psychemedics Corporation 22.09 Million USD -8433.994%
Prenetics Global Limited 21.74 Million USD -8573.459%
Prenetics Global Limited 21.74 Million USD -8573.459%
Precipio, Inc. 15.19 Million USD -12309.304%
Personalis, Inc. 73.48 Million USD -2466.435%
RadNet, Inc. 1.61 Billion USD -16.653%
Sera Prognostics, Inc. 306 Thousand USD -616188.235%
Sotera Health Company 1.04 Billion USD -79.726%
Neuronetics, Inc. 71.34 Million USD -2543.16%
Star Equity Holdings, Inc. 45.78 Million USD -4018.908%
Star Equity Holdings, Inc. 45.78 Million USD -4018.908%
Trinity Biotech plc 56.83 Million USD -3218.275%
Twist Bioscience Corporation 312.97 Million USD -502.555%
Exagen Inc. 52.54 Million USD -3488.799%